Cargando…
A(a)LS: Ammonia-induced amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a dreadful, devastating and incurable motor neuron disease. Aetiologically, it is a multigenic, multifactorial and multiorgan disease. Despite intense research, ALS pathology remains unexplained. Following extensive literature review, this paper posits a new in...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063041/ https://www.ncbi.nlm.nih.gov/pubmed/27785351 http://dx.doi.org/10.12688/f1000research.6364.1 |
_version_ | 1782459900179251200 |
---|---|
author | Parekh, Bhavin |
author_facet | Parekh, Bhavin |
author_sort | Parekh, Bhavin |
collection | PubMed |
description | Amyotrophic lateral sclerosis (ALS) is a dreadful, devastating and incurable motor neuron disease. Aetiologically, it is a multigenic, multifactorial and multiorgan disease. Despite intense research, ALS pathology remains unexplained. Following extensive literature review, this paper posits a new integrative explanation. This framework proposes that ammonia neurotoxicity is a main player in ALS pathogenesis. According to this explanation, a combination of impaired ammonia removal— mainly because of impaired hepatic urea cycle dysfunction—and increased ammoniagenesis— mainly because of impaired glycolytic metabolism in fast twitch skeletal muscle—causes chronic hyperammonia in ALS. In the absence of neuroprotective calcium binding proteins (calbindin, calreticulin and parvalbumin), elevated ammonia—a neurotoxin—damages motor neurons. Ammonia-induced motor neuron damage occurs through multiple mechanisms such as macroautophagy-endolysosomal impairment, endoplasmic reticulum (ER) stress, CDK5 activation, oxidative/nitrosative stress, neuronal hyperexcitability and neuroinflammation. Furthermore, the regional pattern of calcium binding proteins’ loss, owing to either ER stress and/or impaired oxidative metabolism, determines clinical variability of ALS. Most importantly, this new framework can be generalised to explain other neurodegenerative disorders such as Huntington’s disease and Parkinsonism. |
format | Online Article Text |
id | pubmed-5063041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-50630412016-10-25 A(a)LS: Ammonia-induced amyotrophic lateral sclerosis Parekh, Bhavin F1000Res Opinion Article Amyotrophic lateral sclerosis (ALS) is a dreadful, devastating and incurable motor neuron disease. Aetiologically, it is a multigenic, multifactorial and multiorgan disease. Despite intense research, ALS pathology remains unexplained. Following extensive literature review, this paper posits a new integrative explanation. This framework proposes that ammonia neurotoxicity is a main player in ALS pathogenesis. According to this explanation, a combination of impaired ammonia removal— mainly because of impaired hepatic urea cycle dysfunction—and increased ammoniagenesis— mainly because of impaired glycolytic metabolism in fast twitch skeletal muscle—causes chronic hyperammonia in ALS. In the absence of neuroprotective calcium binding proteins (calbindin, calreticulin and parvalbumin), elevated ammonia—a neurotoxin—damages motor neurons. Ammonia-induced motor neuron damage occurs through multiple mechanisms such as macroautophagy-endolysosomal impairment, endoplasmic reticulum (ER) stress, CDK5 activation, oxidative/nitrosative stress, neuronal hyperexcitability and neuroinflammation. Furthermore, the regional pattern of calcium binding proteins’ loss, owing to either ER stress and/or impaired oxidative metabolism, determines clinical variability of ALS. Most importantly, this new framework can be generalised to explain other neurodegenerative disorders such as Huntington’s disease and Parkinsonism. F1000Research 2015-05-14 /pmc/articles/PMC5063041/ /pubmed/27785351 http://dx.doi.org/10.12688/f1000research.6364.1 Text en Copyright: © 2015 Parekh B http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Article Parekh, Bhavin A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title_full | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title_fullStr | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title_full_unstemmed | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title_short | A(a)LS: Ammonia-induced amyotrophic lateral sclerosis |
title_sort | a(a)ls: ammonia-induced amyotrophic lateral sclerosis |
topic | Opinion Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063041/ https://www.ncbi.nlm.nih.gov/pubmed/27785351 http://dx.doi.org/10.12688/f1000research.6364.1 |
work_keys_str_mv | AT parekhbhavin aalsammoniainducedamyotrophiclateralsclerosis |